article thumbnail

Daniel Alexander KC says "no" on indemnity costs, blanket confidentiality orders and permission to appeal in Oxford University Innovation dispute

The IPKat

The AmeriKat ignoring you after being told "no" A few weeks ago, the IPKat reported on the decision in Oxford University Innovation v Oxford Nanoimaging [2022] EWHC 3200 (IPKat report here ). Of the most interesting to this Kat was the treatment of costs (well, some of them), confidentiality and permission to appeal.

article thumbnail

3 Count: Truth Settles

Plagiarism Today

First off today, Chris Cooke at Complete Music Update reports that Lizzo has reached a settlement with her former collaborators over her hit song Truth Hurts. However, now the sides have reached a confidential settlement that brings the case to an end. Have any suggestions for the 3 Count? Let me know via Twitter @plagiarismtoday.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

3 Count: Free Cuthbert

Plagiarism Today

First off today, Blake Brittain at Reuters reports that Sony Music and UK fitness apparel brand Gymshark have settled their lawsuit over Gymshark’s alleged use of Sony’s music in social media posts. However, now it is being reported that the two sides have reached a confidential settlement in the matter.

article thumbnail

Patent vs. Trade Secrets: Making the Right Choice

Intepat

Trade secrets, while cheaper and without time limits, must be kept confidential. Advantages of Patents: Exclusive Rights: In India, the patent holder enjoys various privileges, including the rights to exploit, grant licenses, and assign their patents, allowing others to manufacture and sell the patented items.

Patent 52
article thumbnail

Back to Life (Sciences) in Amsterdam. A conference report

The IPKat

The IPKat reports on some of the trends and topics from the conference below. spoiler: Life Sciences companies will initially highly likely opt-out, whilst certain telecoms giants and licensing assertion entities might be more oriented to test the UPC system by participating in the system.].

article thumbnail

University and Software Company Settle Dispute

BYU Copyright Blog

As we first reported in February of this year, Synopsys asserted that URI had engaged in piracy and had violated the Digital Millennium Copyright Act by using counterfeit licenses to access to Synopsys products. The court further retained jurisdiction to enforce the terms of the confidential agreement.

article thumbnail

Formycon/Fresenius Kabi and Samsung Bioepis Settlements with J&J and Janssen Biotech regarding Ustekinumab

LexBlog IP

In February 2023, Formycon announced its entry into a global license agreement with Fresenius Kabi to commercialize FYB202 in key global markets after successful regulatory approvals. According to the press release, Formycon plans to submit a biologics license application later in 2023 to seek regulatory approval for FBY202.